Q32 Bio Inc. (QTTB)

USD 1.64

(5.13%)

Revenue Summary of Q32 Bio Inc.

  • Q32 Bio Inc.'s latest annual revenue in 2023 was 1.15 Million USD , down -82.62% from previous year.
  • Q32 Bio Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Q32 Bio Inc. reported a annual revenue of 6.65 Million USD in annual revenue 2022, down -80.42% from previous year.
  • Q32 Bio Inc. reported a annual revenue of 33.97 Million USD in annual revenue 2021, up 1157.25% from previous year.
  • Q32 Bio Inc. reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Q32 Bio Inc. reported a quarterly revenue of - USD for 2023 Q4, down -100.0% from previous quarter.

Annual Revenue Chart of Q32 Bio Inc. (2023 - 2016)

Historical Annual Revenue of Q32 Bio Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 1.15 Million USD -82.62%
2022 6.65 Million USD -80.42%
2021 33.97 Million USD 1157.25%
2020 2.7 Million USD 62.18%
2019 1.66 Million USD -68.7%
2018 5.32 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Revenue Comparison of Q32 Bio Inc.

Name Revenue Revenue Difference
Absci Corporation 5.71 Million USD 79.783%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.321%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.937%
Alzamend Neuro, Inc. - USD -Infinity%
Apollomics, Inc. 821 Thousand USD -40.804%
180 Life Sciences Corp. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Bicycle Therapeutics plc 26.97 Million USD 95.715%
Barinthus Biotherapeutics plc 802 Thousand USD -44.14%
BioXcel Therapeutics, Inc. 1.38 Million USD 16.232%
CASI Pharmaceuticals, Inc. 33.87 Million USD 96.588%
Chimerix, Inc. 324 Thousand USD -256.79%
CRISPR Therapeutics AG 371.2 Million USD 99.689%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 97.688%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 97.488%
Fortress Biotech, Inc. 84.51 Million USD 98.632%
Fortress Biotech, Inc. 84.51 Million USD 98.632%
Gritstone bio, Inc. 1.33 Million USD 13.148%
Allakos Inc. - USD -Infinity%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 94.487%
Cytokinetics, Incorporated 7.53 Million USD 84.648%
enGene Holdings Inc. Common Stock - USD -Infinity%
Innoviva, Inc. 310.46 Million USD 99.628%
Hoth Therapeutics, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
ImmuCell Corporation 17.47 Million USD 93.384%
IDEAYA Biosciences, Inc. 23.38 Million USD 95.057%
Incyte Corporation 3.69 Billion USD 99.969%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD -38.941%
Lexaria Bioscience Corp. 226.2 Thousand USD -411.034%
Mustang Bio, Inc. - USD -Infinity%
MiMedx Group, Inc. 321.47 Million USD 99.64%
MEI Pharma, Inc. 65.29 Million USD 98.23%
MacroGenics, Inc. 58.74 Million USD 98.032%
Monopar Therapeutics Inc. - USD -Infinity%
Mereo BioPharma Group plc 10 Million USD 88.44%
Marker Therapeutics, Inc. 3.31 Million USD 65.087%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 96.27%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.6%
Minerva Neurosciences, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
NextCure, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 58.116%
Ocuphire Pharma, Inc. 19.04 Million USD 93.931%
Onconetix, Inc. 58.46 Thousand USD -1877.251%
Oncternal Therapeutics, Inc. 785 Thousand USD -47.261%
Opthea Limited 261.85 Thousand USD -341.459%
Ovid Therapeutics Inc. 391.69 Thousand USD -195.128%
Psyence Biomedical Ltd. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Precigen, Inc. 6.22 Million USD 81.43%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 97.3%
Prime Medicine, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 65.285%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.991%
Replimune Group, Inc. - USD -Infinity%
Revelation Biosciences, Inc. - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.011%
TransCode Therapeutics, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 90.017%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 97.11%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.344%
Solid Biosciences Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
SciSparc Ltd. 2.87 Million USD 59.847%
Sutro Biopharma, Inc. 153.73 Million USD 99.248%
TG Therapeutics, Inc. 233.66 Million USD 99.505%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 85.118%
Titan Pharmaceuticals, Inc. 184 Thousand USD -528.261%
Travere Therapeutics, Inc. 145.23 Million USD 99.204%
UroGen Pharma Ltd. 82.71 Million USD 98.602%
Verrica Pharmaceuticals Inc. 5.12 Million USD 77.44%
XOMA Corporation 4.75 Million USD 75.704%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 96.96%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 97.628%
Dyadic International, Inc. 2.89 Million USD 60.122%
Intensity Therapeutics, Inc. - USD -Infinity%
Eton Pharmaceuticals, Inc. 31.64 Million USD 96.347%
VYNE Therapeutics Inc. 424 Thousand USD -172.642%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 45.728%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 66.971%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.12%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -343.762%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.267%
Syros Pharmaceuticals, Inc. 9.93 Million USD 88.366%
Senti Biosciences, Inc. 2.56 Million USD 54.861%
Mesoblast Limited 5.9 Million USD 80.413%
Kymera Therapeutics, Inc. 78.59 Million USD 98.529%
ChromaDex Corporation 83.57 Million USD 98.617%
BriaCell Therapeutics Corp. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.406%
Dermata Therapeutics, Inc. - USD -Infinity%
Seer, Inc. 15.18 Million USD 92.386%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.295%
Novavax, Inc. 983.7 Million USD 99.882%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 63.53 Million USD 98.18%
Checkpoint Therapeutics, Inc. 103 Thousand USD -1022.33%
Lyell Immunopharma, Inc. 130 Thousand USD -789.231%
Celcuity Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.597%
Phathom Pharmaceuticals, Inc. 682 Thousand USD -69.501%
HOOKIPA Pharma Inc. 20.12 Million USD 94.257%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.97%
Amarin Corporation plc 306.91 Million USD 99.623%
AnaptysBio, Inc. 17.15 Million USD 93.262%
Aptevo Therapeutics Inc. - USD -Infinity%
Aptorum Group Limited 431.37 Thousand USD -167.978%
Cartesian Therapeutics, Inc. 26 Million USD 95.555%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.52%
Ardelyx, Inc. 124.45 Million USD 99.071%
Celularity Inc. 22.77 Million USD 94.923%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.537%
IO Biotech, Inc. - USD -Infinity%
GT Biopharma, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -23020.0%
Pulmatrix, Inc. 7.29 Million USD 84.16%
Intellia Therapeutics, Inc. 36.27 Million USD 96.813%
Evogene Ltd. 5.64 Million USD 79.504%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 75.917%
VistaGen Therapeutics, Inc. 1.06 Million USD -8.647%
Sagimet Biosciences Inc. 2 Million USD 42.2%
PTC Therapeutics, Inc. 937.82 Million USD 99.877%
scPharmaceuticals Inc. 13.59 Million USD 91.496%
Fulcrum Therapeutics, Inc. 2.8 Million USD 58.788%
Corcept Therapeutics Incorporated 482.37 Million USD 99.76%
NLS Pharmaceutics AG - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 86.834%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Outlook Therapeutics, Inc. - USD -Infinity%
ProMIS Neurosciences, Inc. - USD -Infinity%
Daré Bioscience, Inc. 2.8 Million USD 58.83%
bluebird bio, Inc. 29.49 Million USD 96.081%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.952%
DBV Technologies S.A. 15.72 Million USD 92.65%
Avidity Biosciences, Inc. 9.56 Million USD 87.908%
Galecto, Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 88.542%
Inhibrx Biosciences, Inc. 1.8 Million USD 35.778%
GlycoMimetics, Inc. 10 Thousand USD -11460.0%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 98.061%
ADMA Biologics, Inc. 258.21 Million USD 99.552%
Clene Inc. 654 Thousand USD -76.758%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 97.407%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD -37.724%
Century Therapeutics, Inc. 2.23 Million USD 48.277%
Kura Oncology, Inc. - USD -Infinity%
Surrozen, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 94.508%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 98.858%
Autolus Therapeutics plc 1.69 Million USD 31.92%
Mineralys Therapeutics, Inc. - USD -Infinity%
Eterna Therapeutics Inc. 68 Thousand USD -1600.0%
Caribou Biosciences, Inc. 34.47 Million USD 96.647%
GRI Bio, Inc. 21.76 Million USD 94.689%
Xenetic Biosciences, Inc. 2.53 Million USD 54.488%
Janux Therapeutics, Inc. 8.08 Million USD 85.698%
INmune Bio, Inc. 155 Thousand USD -645.806%
Heron Therapeutics, Inc. 127.04 Million USD 99.09%
SAB Biotherapeutics, Inc. 2.23 Million USD 48.37%
Pasithea Therapeutics Corp. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 88.157%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD -15.6%
Clearside Biomedical, Inc. 8.22 Million USD 85.947%
Atara Biotherapeutics, Inc. 8.57 Million USD 86.516%
Coherus BioSciences, Inc. 257.24 Million USD 99.551%
Verastem, Inc. - USD -Infinity%
Pliant Therapeutics, Inc. 1.58 Million USD 26.835%
Histogen Inc. 3.76 Million USD 69.329%
Aprea Therapeutics, Inc. 583.23 Thousand USD -98.206%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.841%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -960.55%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 83.131%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
BioRestorative Therapies, Inc. 145.8 Thousand USD -692.867%
Kronos Bio, Inc. 6.28 Million USD 81.616%
Turnstone Biologics Corp. 19.3 Million USD 94.012%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Entrada Therapeutics, Inc. 129.01 Million USD 99.104%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.341%
Exelixis, Inc. 1.83 Billion USD 99.937%
Nurix Therapeutics, Inc. 76.98 Million USD 98.498%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.709%
Jasper Therapeutics, Inc. - USD -Infinity%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.174%
Insmed Incorporated 305.2 Million USD 99.621%
MediWound Ltd. 18.68 Million USD 93.814%
OmniAb, Inc. 34.16 Million USD 96.616%
Alector, Inc. 97.06 Million USD 98.809%
Seres Therapeutics, Inc. 126.32 Million USD 99.085%
Zai Lab Limited 266.71 Million USD 99.567%
AlloVir, Inc. - USD -Infinity%
Revance Therapeutics, Inc. 234.04 Million USD 99.506%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 93.374%
Veracyte, Inc. 361.05 Million USD 99.68%
InMed Pharmaceuticals Inc. 4.59 Million USD 74.857%
FibroGen, Inc. 147.75 Million USD 99.218%
SeaStar Medical Holding Corporation - USD -Infinity%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.71%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -682.112%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -175.238%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.696%
Fortrea Holdings Inc. 3.1 Billion USD 99.963%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -665.563%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 25.802%
Foghorn Therapeutics Inc. 34.15 Million USD 96.615%
Agenus Inc. 156.31 Million USD 99.26%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 98.637%
Theravance Biopharma, Inc. 57.42 Million USD 97.987%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.734%
Metagenomi, Inc. Common Stock 44.75 Million USD 97.417%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.651%
Gain Therapeutics, Inc. 55.18 Thousand USD -1994.962%
C4 Therapeutics, Inc. 20.75 Million USD 94.431%
Creative Medical Technology Holdings, Inc. 9000.00 USD -12744.444%
Chemomab Therapeutics Ltd. - USD -Infinity%
Lantern Pharma Inc. - USD -Infinity%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -846.672%
Pluri Inc. 326 Thousand USD -254.601%
Prothena Corporation plc 91.37 Million USD 98.735%
Adaptimmune Therapeutics plc 60.28 Million USD 98.082%
Rallybio Corporation - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 78.944%
MeiraGTx Holdings plc 14.01 Million USD 91.753%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 83.862%
Moderna, Inc. 6.84 Billion USD 99.983%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 98.191%
Blueprint Medicines Corporation 249.38 Million USD 99.536%
Immix Biopharma, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Scholar Rock Holding Corporation - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 98.98%
Sana Biotechnology, Inc. - USD -Infinity%
Elicio Therapeutics, Inc. - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 76.86%
Nutriband Inc. 2.08 Million USD 44.565%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.074%
Alkermes plc 1.66 Billion USD 99.931%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 88.432%
Arcellx, Inc. 110.31 Million USD 98.952%
BridgeBio Pharma, Inc. 9.3 Million USD 87.574%
Tango Therapeutics, Inc. 36.52 Million USD 96.835%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD -268.153%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
MediciNova, Inc. 1 Million USD -15.6%
Praxis Precision Medicines, Inc. 2.44 Million USD 52.758%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -6674.099%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.573%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -387.764%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 94.422%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.572%
Royalty Pharma plc 2.35 Billion USD 99.951%
Ventyx Biosciences, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -1116.842%
Larimar Therapeutics, Inc. - USD -Infinity%
Mersana Therapeutics, Inc. 36.85 Million USD 96.863%
Structure Therapeutics Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
Kezar Life Sciences, Inc. 7 Million USD 83.486%
aTyr Pharma, Inc. 353 Thousand USD -227.479%
Aligos Therapeutics, Inc. 15.52 Million USD 92.556%
Viridian Therapeutics, Inc. 314 Thousand USD -268.153%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -9486.201%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.861%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 3.987%
Liquidia Corporation 17.48 Million USD 93.39%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.415%
Arbutus Biopharma Corporation 18.14 Million USD 93.628%
Xencor, Inc. 168.33 Million USD 99.313%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -355.884%
Pasithea Therapeutics Corp. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.4%
Lexaria Bioscience Corp. 226.2 Thousand USD -411.034%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -6674.099%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 23.087%
Qualigen Therapeutics, Inc. 5.2 Million USD 77.79%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 25.611%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 98.507%
CollPlant Biotechnologies Ltd. 10.95 Million USD 89.452%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.95%
HilleVax, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -1503.284%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.529%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Windtree Therapeutics, Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 88.467%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.953%
Protagonist Therapeutics, Inc. 60 Million USD 98.073%
Erasca, Inc. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 85.561%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Celldex Therapeutics, Inc. 6.88 Million USD 83.205%
Cogent Biosciences, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.711%
Aditxt, Inc. 645.17 Thousand USD -79.176%
Adagene Inc. 18.11 Million USD 93.617%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD -6.839%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.538%
Compugen Ltd. 33.45 Million USD 96.545%
Generation Bio Co. 5.9 Million USD 80.42%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 95.475%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 98.805%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 98.848%
Instil Bio, Inc. - USD -Infinity%
Capricor Therapeutics, Inc. 25.17 Million USD 95.409%
Elevai Labs, Inc. Common Stock 1.71 Million USD 32.5%
GeoVax Labs, Inc. - USD -Infinity%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 98.659%
Evaxion Biotech A/S 73.11 Thousand USD -1481.136%
Ocular Therapeutix, Inc. 58.44 Million USD 98.022%
Verve Therapeutics, Inc. 11.75 Million USD 90.168%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Bolt Biotherapeutics, Inc. 7.87 Million USD 85.322%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD -85.852%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 78.758%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 98.352%
Celularity Inc. 22.77 Million USD 94.923%
Aileron Therapeutics, Inc. - USD -Infinity%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 71.194%
Virax Biolabs Group Limited 156.41 Thousand USD -639.041%
Cibus, Inc. 1.81 Million USD 36.379%
IN8bio, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 67.889%
Avalo Therapeutics, Inc. 1.92 Million USD 39.917%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.853%
Eyenovia, Inc. 3787.00 USD -30425.482%
Puma Biotechnology, Inc. 235.63 Million USD 99.509%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Cardiff Oncology, Inc. 488 Thousand USD -136.885%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 98.54%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD -27.728%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 82.922%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD -57.521%
Humacyte, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -580.0%
Trevi Therapeutics, Inc. - USD -Infinity%
Notable Labs, Ltd. 310 Thousand USD -272.903%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD -6.839%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 37.916%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Nuvectis Pharma, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 75.704%
ARS Pharmaceuticals, Inc. 30 Thousand USD -3753.333%
Bionomics Limited - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 92.703%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 98.213%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD -171.362%
LENZ Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -214.235%
Zevra Therapeutics, Inc. 27.46 Million USD 95.79%
Benitec Biopharma Inc. 216 Thousand USD -435.185%
Spyre Therapeutics, Inc. 886 Thousand USD -30.474%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
argenx SE 1.22 Billion USD 99.906%
Immunome, Inc. 14.01 Million USD 91.753%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 30.235%
CervoMed Inc. 7.14 Million USD 83.821%
Plus Therapeutics, Inc. 4.91 Million USD 76.471%
Dianthus Therapeutics, Inc. 2.82 Million USD 59.094%
Moolec Science SA 905.04 Thousand USD -27.728%
Enveric Biosciences, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 47.526%
Achilles Therapeutics plc - USD -Infinity%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -466.667%
Fractyl Health, Inc. Common Stock 120 Thousand USD -863.333%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.694%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.38%
AEON Biopharma, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 95.253%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 53.009%
Iovance Biotherapeutics, Inc. 1.18 Million USD 2.775%
Lumos Pharma, Inc. 2.05 Million USD 43.637%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 97.161%
Palisade Bio, Inc. 250 Thousand USD -362.4%
Nutriband Inc. 2.08 Million USD 44.565%
Taysha Gene Therapies, Inc. 15.45 Million USD 92.518%
Neurogene Inc. - USD -Infinity%
Kintara Therapeutics, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Athira Pharma, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 59.321%
XOMA Corporation 4.75 Million USD 75.704%
Nektar Therapeutics 90.12 Million USD 98.717%
Arvinas, Inc. 78.5 Million USD 98.527%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 97.37%
Omega Therapeutics, Inc. 3.09 Million USD 62.637%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD -76.758%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 33.981%
Synlogic, Inc. 3.37 Million USD 65.708%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -214.235%
Werewolf Therapeutics, Inc. 19.94 Million USD 94.203%
Krystal Biotech, Inc. 50.69 Million USD 97.72%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.208%
SpringWorks Therapeutics, Inc. 5.44 Million USD 78.777%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD -157.108%
MannKind Corporation 198.96 Million USD 99.419%
Ikena Oncology, Inc. 9.16 Million USD 87.38%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 98.981%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.595%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 97.695%
REGENXBIO Inc. 90.24 Million USD 98.719%
Ensysce Biosciences, Inc. 2.23 Million USD 48.174%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 84.334%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD -53.113%
Longeveron Inc. 709 Thousand USD -63.047%
Repare Therapeutics Inc. 51.13 Million USD 97.739%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.907%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 90.017%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -450.476%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.988%
Denali Therapeutics Inc. 330.53 Million USD 99.65%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 92.907%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 57.233%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -658.381%
Carisma Therapeutics, Inc. 14.91 Million USD 92.251%
Unicycive Therapeutics, Inc. 675 Thousand USD -71.259%
OmniAb, Inc. 34.16 Million USD 96.616%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 94.561%
Lipocine Inc. -2.85 Million USD 140.55%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 48.37%
G1 Therapeutics, Inc. 82.51 Million USD 98.599%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 98.663%
Ocugen, Inc. 6.03 Million USD 80.848%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 96.796%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 80.74%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 43.306%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.9%
Agios Pharmaceuticals, Inc. 26.82 Million USD 95.69%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.801%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 90.822%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD -142.348%
Iterum Therapeutics plc - USD -Infinity%